ARCHIVES

Anti-Nausea Drug Successful In Phase III Trial in Highly Emetogenic Chemotherapy

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

American Association for Cancer Research Presents Awards at 2012 Annual Meeting

April 6, 2012

Program Announcement Completes NCI switch To Control Research

April 16, 1982

In Brief: Nabel To Direct Vaccine Research Center; Former NIH Director Robert Marston Is Dead

March 19, 1999

House Figures for NCI, NIH Will Be Known This Week; Senate Probably Will Wait Until After Recess

July 31, 1987

Rep. Wyden Questions NCI Motive For Choosing Not To Pursue RU 486

September 4, 1992

FDA Approves New Indication For Anticoagulant Frangmin

May 25, 2007